Glyvanza 30 mg Modified Release Tablet

  • Glyvanza 30 mg Modified Release Tablet

Glyvanza 30 mg Modified Release Tablet


Division Human Health
Generic Name Gliclazide
Therapeutic Segment Endocrine, Metabolic & Antidiabetic Medications
Form Modified Release Tablet
Indication Glyvanza 30 mg is a medicine that reduces blood sugar levels (oral antidiabetic medicine belonging to the sulfonylurea group). Glyvanza 30 mg is used in a certain form of diabetes (type 2 diabetes mellitus) in adults, when diet, exercise and weight loss alone do not have an adequate effect on keeping blood sugar at the correct level.
Pack 30 tablets
Strength 30 mg